Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I-Stem) France

Research

Date range: 1 May 2021 - 30 April 2022

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I-Stem) published between 1 May 2021 - 30 April 2022 which are tracked by the Nature Index.

Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Article Count and Share for Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I-Stem)
Count Share
1 0.91

Outputs by subject (Share)

Outputs by subject
Subject Count Share
1 0.91

Share output for the past 5 years

Share per year
2016 2017 2018 2019 2020
0.00 0.68 0.00 0.41 0.16

Compare Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I-Stem) with other institutions

Collaboration

Date range: 1 May 2021 - 30 April 2022

International vs. domestic collaboration by Share

  • 100.00% Domestic
  • 0.00% International

Hover over the graph to view the percentage of collaboration.


Top 10 domestic collaborators with Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I-Stem) by Share (12 total)

  1. Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I-Stem) and National Institute for Health and Medical Research (INSERM) (1.28)
    Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I-Stem)0.91
    National Institute for Health and Medical Research (INSERM)0.37
  2. Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I-Stem) and French Muscular Dystrophy Association (AFM-Téléthon) (1.21)
    Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I-Stem)0.91
    French Muscular Dystrophy Association (AFM-Téléthon)0.30
  3. Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I-Stem) and Infrastructure Nationale d'Ingénierie des Cellules Souches Pluripotentes et Cellules Différenciées (INGESTEM) (1.21)
    Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I-Stem)0.91
    Infrastructure Nationale d'Ingénierie des Cellules Souches Pluripotentes et Cellules Différenciées (INGESTEM)0.30
  4. Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I-Stem) and University of Montpellier (0.96)
    Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I-Stem)0.91
    University of Montpellier0.05
  5. Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I-Stem) and University of Paris-Sud (UPSud) (0.96)
    Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I-Stem)0.91
    University of Paris-Sud (UPSud)0.05
  6. Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I-Stem) and University of Strasbourg (0.96)
    Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I-Stem)0.91
    University of Strasbourg0.05
  7. Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I-Stem) and University of Évry-Val d'Essonne (UEVE) (0.96)
    Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I-Stem)0.91
    University of Évry-Val d'Essonne (UEVE)0.05
  8. Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I-Stem) and French National Centre for Scientific Research (CNRS) (0.96)
    Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I-Stem)0.91
    French National Centre for Scientific Research (CNRS)0.05
  9. Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I-Stem) and Oncogenesis Stress Signaling (OSS) (0.95)
    Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I-Stem)0.91
    Oncogenesis Stress Signaling (OSS)0.05
  10. Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I-Stem) and Centre de Lutte Contre le Cancer Eugène Marquis (Rennes) (0.95)
    Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I-Stem)0.91
    Centre de Lutte Contre le Cancer Eugène Marquis (Rennes)0.05

Top 10 international collaborators with Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I-Stem) by Share (0 total)

Relationships

Partner Institutions

Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I-Stem) is a research collaboration whose article contributions are accrued to its participating partner institutions below.